PLASMINOGEN ACTIVATOR INHIBITOR IN PLASMA: RISK FACTOR FOR RECURRENT MYOCARDIAL INFARCTION
- 1 July 1987
- journal article
- research article
- Published by Elsevier in The Lancet
- Vol. 330 (8549) , 3-9
- https://doi.org/10.1016/s0140-6736(87)93050-9
Abstract
No abstract availableKeywords
This publication has 36 references indexed in Scilit:
- The use of biplane angiocardiography for the measurement of left ventricular volume in manPublished by Elsevier ,2004
- Increased Plasma Levels of a Rapid Inhibitor of Tissue Plasminogen Activator in Young Survivors of Myocardial InfarctionNew England Journal of Medicine, 1985
- Fibrinogen as a Risk Factor for Stroke and Myocardial InfarctionNew England Journal of Medicine, 1984
- Improvement of regional myocardial metabolism after coronary thrombolysis induced with tissue-type plasminogen activator or streptokinase.Circulation, 1984
- Coronary artery surgery study (CASS): a randomized trial of coronary artery bypass surgery. Survival data.Circulation, 1983
- Prognostic value of exercise testing, coronary angiography and left ventriculography 6--8 weeks after myocardial infarction.Circulation, 1982
- Determinants of Prognosis in Survivors of Myocardial InfarctionNew England Journal of Medicine, 1982
- Predictors of clinical course, coronary anatomy and left ventricular function after recovery from acute myocardial infarction.Circulation, 1980
- Nomenclature and criteria for diagnosis of ischemic heart disease. Report of the Joint International Society and Federation of Cardiology/World Health Organization task force on standardization of clinical nomenclature.Circulation, 1979
- A reporting system on patients evaluated for coronary artery disease. Report of the Ad Hoc Committee for Grading of Coronary Artery Disease, Council on Cardiovascular Surgery, American Heart AssociationCirculation, 1975